Company Details
- Employees
- 72
- Address
- 171 Oyster Point Blvd, South San Francisco,california 94080,united States
- ca****@****zen.com
- Industry
- Biotechnology
- Website
- surrozen.com
- HQ
- South San Francisco, California
Please complete the CAPTCHA to continue
Wnt Pathway Therapeutics Pioneer Surrozen to Showcase Pipeline at Major Healthcare Conference Sept 10 Stock Titan
Surrozen, Inc. Prioritizes Ophthalmology Pipeline with $175 Million Financing and Discontinues SZN-043 Development Nasdaq
Institutions own 32% of Surrozen, Inc. (NASDAQ:SRZN) shares but private equity firms control 32% of the company Yahoo Finance
Surrozen drops sole clinical-stage drug over weak hepatitis data, pivots to eye disease Fierce Biotech
Surrozen drops hepatitis drug after Phase I flop Clinical Trials Arena
Surrozen secures patent for tissue repair technology Investing.com
45,710 Shares at $12.32: Surrozen's Latest Stock Option Grants for New Biotech Talent Expansion Stock Titan
Surrozen Secures $175Mln In Oversubscribed Private Placement To Advance Ophthalmology Pipeline Nasdaq
Combining price and volume data for Surrozen Inc. - CEO Change & Accurate Intraday Trade Tips newser.com
Novel Frizzled-specific antibody-based Wnt mimetics and Wnt superagonists selectively activate WNT/β-catenin signaling in target tissues ScienceDirect.com
Companies Like Surrozen (NASDAQ:SRZN) Are In A Position To Invest In Growth Sahm
StemPoint Capital LP Increases Stake in Surrozen Inc GuruFocus
How Surrozen Inc. stock responds to policy changes - July 2025 Summary & Consistent Return Strategy Ideas Trung tâm Dự báo KTTV quốc gia
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules Yahoo Finance
Real time alert setup for Surrozen Inc. performance - July 2025 News Drivers & High Accuracy Investment Signals newser.com
How Surrozen Inc. Equity Warrant stock performs in rate cut cycles - Buy Signal & Comprehensive Market Scan Reports Trung tâm Dự báo KTTV quốc gia
Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration Stock Titan
Predicting Surrozen Inc. Equity Warrant trend using moving averages - IPO Watch & Free Technical Pattern Based Buy Signals newser.com
Can Surrozen Inc. stock sustain institutional interest - 2025 EndofYear Setup & Precise Buy Zone Identification Trung tâm Dự báo KTTV quốc gia
Momentum divergence signals in Surrozen Inc. Equity Warrant chart - Trade Volume Report & Low Risk Profit Maximizing Plans newser.com
Surrozen announces partnership with Boehringer Ingelheim to develop Wnt agonist SZN-413 for people diagnosed with retinal diseases Ophthalmology Times
Surrozen stops IBD program due to dose concerns and competition Fierce Biotech
Surrozen’s Collaboration Agreement with TCGFB Terminated TipRanks
Design principles and therapeutic applications of novel synthetic WNT signaling agonists ScienceDirect.com
Liver enzyme elevations in healthy volunteers prompts soul searching at Surrozen Fierce Biotech
How Surrozen Inc. Equity Warrant stock performs in rate cut cycles - New Guidance & Low Risk Entry Point Guides Fundação Cultural do Pará
Is Surrozen Inc. stock a dividend growth opportunity - Stock Surge & Weekly Return Optimization Plans Fundação Cultural do Pará
Surrozen culls at least 2 research programs to funnel more money toward clinical work Fierce Biotech
Is Surrozen Inc. stock affected by interest rate hikes - Market Rally & Accurate Entry/Exit Alerts Trung tâm Dự báo KTTV quốc gia
Boehringer and Surrozen Seek Retinal Therapies Along the Wnt Pathway BioSpace
Boehringer sets sights on Surrozen's preclinical retinal disease asset in $600M deal Fierce Biotech
Boehringer Ingelheim to advance SZN-413 for retinal diseases BioWorld MedTech
Surrozen cuts inflammatory bowel disease drug as cash, stock drop The Business Journals
Alyeska Investment Group L.P. Expands Portfolio with Surrozen In GuruFocus
H.C. Wainwright Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $32 富途牛牛
Surrozen, Inc. Receives Notice from TCGFB, Inc. to Terminate the Collaboration Agreement MarketScreener
Regenerative medicine biotech Surrozen aims for the Nasdaq in $212M SPAC deal Fierce Biotech
What are the technical indicators suggesting about Surrozen Inc. - Capitalize on market trends with confidence Jammu Links News
Smart Money: Is Surrozen Inc. stock affected by interest rate hikes - Weekly Stock Analysis & Real-Time Volume Trigger Notifications Fundação Cultural do Pará
Surrozen Chooses TransPerfect’s Trial Interactive eClinical Platform for Comprehensive TMF Management Business Wire
Wnt-focused Surrozen bags $50M to push regenerative medicine for liver disease Fierce Biotech
Surrozen (SRZN) Stock Price, News & Analysis MarketBeat
Critical Contrast: Surrozen (NASDAQ:SRZN) and Scienture (NASDAQ:SCNX) Defense World
1 +121583XXXXX
5 +165086XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.